Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 53 , ISSUE 1 ( January-March, 2019 ) > List of Articles


Adverse Drug Reactions to Disulfiram Treatment with or without Alcohol Challenge in the Indian Setting: Systematic Review

Jaison Joseph, Debasish Basu

Keywords : Adverse drug reaction, Disulfiram, India

Citation Information : Joseph J, Basu D. Adverse Drug Reactions to Disulfiram Treatment with or without Alcohol Challenge in the Indian Setting: Systematic Review. J Postgrad Med Edu Res 2019; 53 (1):21-30.

DOI: 10.5005/jp-journals-10028-1307

License: CC BY-NC 4.0

Published Online: 01-12-2018

Copyright Statement:  Copyright © 2019; The Author(s).


ABSTRACT Background: Disulfiram has been used for treating alcohol dependence in the Indian population for the last three decades. The safety concerns associated with adverse effectsraise a high index of suspicion for disulfiram therapy in Indian population. Surprisingly few reviews exist on adverse reaction to disulfiram treatment and most of such articles published during the 1990s. Moreover, such systematic investigation relevant to the Indian population is missing in the literature. Thepresent review aims to narrate and discuss disulfiram induced adverse reactionsin the Indian setting. Materials and methods: We analyzed clinical trials, observational studies and case reports of adverse drug reactions to disulfiram therapy reportedin the Indian setting. Relevant studies published within 2017 in the electronic databases: Medline, Ind MED, Ermed, and Embase were included. The Naranjo adverse drug reaction probability scale (NADRPS) was used for assessing adverse drug reactions to disulfiram treatment. Results: The present review identified four open-label trials, four observational studies and 24 case reports describing thirtytwo cases of disulfiram-induced adverse reactions in the Indian setting. Psychiatric adverse events and de novo convulsions were the common adverse reactions to disulfiram treatment without alcohol challenge in this setting. The NADRPS score was found to be from 5–9 and the magnitude of the adverse effects associated with disulfiram-ethanol reaction was largely associated with surreptitious use. Conclusion: The review is a pioneer attempt for an evidence base summary of common adverse reactions and temporal association of dose-dependent adverse effects to disulfiram treatment in the Indian setting. The results of the review open an area of discussion regarding ethnic variations and the adverse effects of disulfiram in clients treated for alcohol dependence in this setting.

PDF Share
  1. Rehm J, Imtiaz S. A narrative review of alcohol consumption as a risk factor for global burden of disease. Subst Abuse Treat Prev Policy. 2016;11(1):37.
  2. Pal A, Pattanayak RD, Sagar R. Tracing the journey of disulfiram: From an unintended discovery to a treatment option for alcoholism. J Mental Health Hum Behav 2015;20:41-43.
  3. Kalra G, De Sousa A, Shrivastava A. Disulfiram in the management of alcohol dependence: a comprehensive clinical review. O J Psych. 2014;4:43-52.
  4. Savas MC, Gullu JH. The disulfiram ethanol reaction: the significance of supervision. Annals of Pharmacotherapy. 1997;31:374-375.
  5. Abraham J, Chandrasekaran R, Chitralekha V. A prospective study of treatment outcome in alcohol dependence from a deaddiction centre in India. Indian J Psychiatry. 1997;31:374- 375.
  6. Prasad S, Murthy P, Subbakrishna DK, Gopinath PS. Treatment setting and follow-up in alcohol dependence. Indian J Psychiatry. 2000;42(4):387-392.
  7. Chandrasekaran R, Sivaprakash B, Chitraleka V. Five years of alcohol de-addiction services in a tertiary care general hospital. Indian J Psychiatry. 2001;43(1):58.
  8. Galgali RB, Srinivasan K, Souza GD. Study of spirometry and airway reactivity in patients on disulfiram for treatment of alcoholism. Indian J Psychiatry. 2002;44:273.
  9. Sidana A, Rai S, Chavan BS. Alcohol Dependence Syndrome: One year outcome study Delhi Psychiatry Journal 2007;10(1):53-57.
  10. Singh SM, Mattoo SK, Dutt A, Chakrabarti K, Nebhinani N, Kumar S, et al. Long-termoutcome of in-patients with substance use disorders: A study from North India. Indian J Psychiatry 2008;50:269-273.
  11. Chand P, Naveen CK, Murthy P, Isaac M. Addressing alcohol addiction: lessons from a hospital based audit. Indian J Med Res. 2013 Feb;137(2):394-396.
  12. Balhara YP, Ranjan R, Dhawan A, Yadav D. Experiences from a community based substance use treatment centre in an urban resettlement colony in India. Journal of addiction. 2014;2014.
  13. Krampe H, Ehrenreich H. Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des. 2010;16(19):2076-2090.
  14. Skinner MD, Lahmek P, Pham H, Aubin HJ. Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PloS one. 2014 Feb 10;9(2):e87366.
  15. Crowley P. Long-term drug treatment of patients with alcohol dependence. Aust Prescr. 2015 Apr;38(2):41-43.
  16. Sharma P, Murthy P, Bharath MM. Disulfiram in a “traditional” medicine sold to patients with alcohol dependence in India. Addiction. 2011;106:1870-1871.
  17. Sarkar S. Surreptitious use of disulfiram. Indian J Med Ethics. 2013;10(1):71.
  18. Chakraborty PK, Singh H, Divinakumar KJ. Current status of disulfiram therapy. MJAFI. 2001 Oct 1;57(4):320-321.
  19. Poulsen HE, Loft S, Andersen JR, Andersen M. Disulfiram therapy–adverse drug reactions and interactions. Acta Psychiatrica Scandinavica. 1992 Nov;86(S369):59-66.
  20. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. Journal of medical case reports. 2013 Dec;7(1):223.
  21. Rison RA, Kidd MR, Koch CA. The CARE (CAse REport) guidelines and the standardization of case reports. 2013;7:261.
  22. Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
  23. De Sousa A, De Sousa A. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol. 2004;39:528-531.
  24. De Sousa A, De Sousa A. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol. 2005;40:545-548.
  25. De Sousa AA, De Sousa J, Kapoor H. An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence. J Subst Abuse Treat. 2008;34:460-463.
  26. De Sousa A, De Sousa A. An open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence. Journal of Substance Use. 2009;13:382-388.
  27. Bagadia VN, Dhawale KM, Shah LP, Pradhan PV. Evaluation of disulfiram in the treatment of alcoholism. Indian J Psychiatry. 1982;249(3):242-247.
  28. Srinivasan TN, Suresh TR, Vasantha J. Adverse effects of disulfiram and patient compliance. Indian J Psychiatry 1996; 38:47-50.
  29. Murthy KK. Psychosis during disulfiram therapy for alcoholism. J Indian Med Assoc. 1997 Mar;95(3):80-81.
  30. Palatty PL, Saldanha E. Status of disulfiram in present day alcoholic deaddiction therapy. Indian J Psychiatry 2011; 53:25-29.
  31. Singh H. et al. Disulfiram Induced Psychosis. J Addict Depend. 2017;3(2):1-3.
  32. Mohapatra S, Rath RN. Disulfiram induced psychosis. Clinical Psychopharmacology and Neuroscience. 2017;15(1):68-69.
  33. Thamizh JS, Menon V, Selvakumar N, Rajkumar RP. Treatment- emergent psychosis with disulfiram in a patient with late-onset alcohol use disorder and no contributory factors. J Clin Psychopharmacol. 2016; 36(5):535-537.
  34. Alamela VS, Desai M, Arunkumar C. Disulfiram-induced dystonia. J Sci Soc 2016;43:80-81.
  35. Kumar KK, Bondade S, Sattar AF, Singh N. Malignant catatonia and neuroleptic malignant syndrome in relation to disulfiram overdose. Indian J Psychol Med. 2016;38(4):344-347.
  36. Goswami HK, Bhuyan D, Talukdar B. Catatonia induced by disulfiram. Open Journal of Psychiatry & Allied Sciences. 2015;6(2):143-145.
  37. Vrishabhendraiah SS, Gopal Das CM, Jagadeesh MK, Mruthyunjaya N. Disulfiram-induced seizures with convulsions in a young male patient: a case study. Indian J Psychiatry 2015;57:309-310.
  38. Mohapatra S, Sahoo MR, Rath N. Disulfiram-induced neuropathy: a case report. Gen Hosp Psychiatry. 2015;18(1).
  39. Kukreti P, Dhiman V, Garg A. Disulfiram withdrawal delirium and non hepatic hyperammonemia: diagnostic dilemma and therapeutic challenge. Delhi Psychiatry Journal. 2015;18(1).
  40. Kulkarni RR, Bairy KB. Disulfiram-induced de novo convulsions: Case series. Indian J Psychol Med. 2015;37(3):345-348.
  41. Layek AK. Peripheral neuropathy: case report. Reactions Weekly. 2014;1521(1):67.
  42. Sreejayan K, Praharaj, SK. Myoclonus associated with disulfiram. Journal of Neuropsychiatry and Clinical Neurosciences. 2013;25(2):37-39.
  43. Tesia SS, Tesia P, Gowda MR, Preethi. Disulfiram Induced Enuresis. Asian Journal of Biochemical and Pharmaceutical Research. 2013;3(3).
  44. Kulkarni RR, Bairy KB. Disulfiram induced reversible hypertension. Indian J Psychol Med. 2013;35(2):217-219.
  45. Nayak V, Chogtu B, Virupaksha D, Bhandary PV. Disulfiram induced catatonia. Case Study Case Rep. 2011;1(1):6-8.
  46. Saddichha S, Phutane V, Thirthalli J. De novo dose-dependent catatonia due to disulfiram therapy: a report and review. Journal of Clinical Pharmacology. 2011;51:285-286.
  47. Basu D, Sharma A, Nebhinani N. Disulfiram-induced delirium. JMHHB 2009;14(2):105-107.
  48. Zawar V, Nerikar S. Dermatitis recall during disulfiram therapy. Indian J Dermatol Venereol Leprol. 2004;70:33-35.
  49. Ravishankar M, Rakshith N. Disulfiram induced hemoptysis: a case report. International Journal of Basic & Clinical Pharmacology. 2016;5(1):220.
  50. Jadhav PB. Disulfiram-induced toxic pustuloderma (acute generalized exanthematous pustulosis). Indian J Drugs Dermatol. 2016;2:31-32.
  51. Ghosh S, Bhuyan D, Zaman UR. Catatonia associated with disulfiram therapy following disulfiram ethanol reaction. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 2015;14(3):77-79.
  52. Babu SM, Shetty CS, Aiyappa MR, Sameer S. Disulfiram Ethanol Reaction with Ischemic Stroke. Eur J Gen Med 2014;11(3):190-192.
  53. Manjunatha N, Vidyendaran R, Rao MG, Kulkarni GB, Muralidharan K, John JP, et al. Subacute vocal cord paralysis, facial palsy and paraesthesias of lower limbs following surreptitious administration of disulfiram. J Neurol Neurosurg Psychiatry. 2010;81(12):1409-1410.
  54. Sherif AP. Krishna Murthy K. Psychosis and enuresis during disulfiram therapy. Indian J Psychiatry. 2006;48(1):62-63.
  55. Chick J. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Safety. 1999;20:427-435.
  56. Chen YC, Yin SJ. Ethnic differences of disulfiram pharmacogenetic effect in Asian population. Sy18-1. Alcohol and Alcoholism. 2014;49(1).
  57. Cservenka A, Yardley MM, Ray AL. Review: Pharmacogenetics of alcoholism treatment: implications of ethnic diversity. The American Journal on Addictions. 2017;26:516–525.
  58. Matsushita S, Higuchi S. Review: Use of Asian samples in genetic research of alcohol use disorders: genetic variation of alcohol metabolizing enzymes and the effects of acetaldehyde. The American Journal on Addictions. 2017;26:469-476.
  59. Grover S, Basu D. The revival (or, rather, survival) of disulfiram. Addiction. 2004;99(6):785.
  60. Das N, Mahapatra A, Sarkar S. Disulfiram induced psychosis: Revisiting an age-old entity. Asian Journal of Psychiatry. 2017;30: 94-95.
  61. Park WC, Riggio S. Disulfiram—Ethanol Induced Delirium. Annals of pharmacotherapy. 2001;35(1):32-35.
  62. Mirsal H, Yalug I, Tan D, Stern AT, Kalyoncu A, Pektas O, et al. Delirium-Associated Disulfiram and Ethanol Interactions. Prim Care Companion J Clin Psychiatry. 2005;7(5):235-237.
  63. Takacs R, Milan F, Ungvari GS, Faludi G, Gazdag G. Catatonia in disulfiram intoxication - a case report and a brief overview of the literature. Neuropsychopharmacol Hung. 2016;18(2):110-114.
  64. Ajish G. Ethical aspects of surreptitious use of disulfiram. Journal of Substance Use. 2016; 22(3):244-245.
  65. Ajish G, Vasantmeghna MS. Jamale S. Pattern of prescription, dispensation and administration of disulfiram among patients with alcohol use disorder attending a general hospital psychiatry unit in rural India. Asian Journal of Psychiatry. 2017; 28:170-174.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.